Big Data, Big Benefits: How Third-Party Data Can Improve Clinical Trials

Large data and data analytics have been adopted across the life sciences and are driving significant industry changes. In clinical research, big data presents possibilities ranging from better patient recruitment and engagement to more efficient studies and better-quality results.

Using large data strategies could also build better tools for doctors, medical insurance companies, and consumers. Researchers from McKinsey predict that the future of big data in clinical trials will lead to better predictive modeling of biological processes and drugs through molecular and clinical data.

Given the many sources from which this data is generated, it’s inevitable that trial sponsors and managers will need to partner with third parties to access this vital resource. Explore the opportunities big data presents, as well as the considerations and possibilities involved for clinical trial operations when third-party data is used.